Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: COUR Pharmaceuticals Development Company Inc.
September 12, 2025
COUR Pharmaceuticals Development Company Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of myasthenia gravis (MG)
Disease Area:
Rare Diseases
Source
Source
Scroll to Top
